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DWS Lam  
SV Lo  Objective. To estimate the total domestic health expenditure in Hong Kong
between fiscal years 1989/90 and 2001/02, with breakdown by financing source,
provider, and function over time.
Methods. The standard health accounting methods as per the Organisation
for Economic Co-operation and Development System of Health Accounts guide-
lines of 2000 were adopted.
Results. Total domestic health expenditure was $68 620 million in the fiscal
year 2001/02. In real terms, expenditure grew at an average rate of 7% while
gross domestic product increased by 4% during the same period. This indicates a
growing share of health spending relative to gross domestic product, from 3.8%
in 1989/90 to 5.5% in 2001/02. This upward trend was largely driven by in-
creased public spending that rose 208% in real terms over the period, compared
with 76% for private spending. Out-of-pocket payments by households accounted
for about 70% of private spending while employers and insurance accounted for
28%. Private insurance plays an increasingly important role in financing private
spending whereas household expenditure has shown a corresponding decrease
during the period. Expenditure incurred at providers of ambulatory services
and hospitals accounted for more than 70% of total health expenditure during
the observed period. Hospitals’ share of total spending increased by 18%, reach-
ing 45% of total expenditure in 2001/02, whilst the share of providers of ambu-
latory services reduced to 30% in 2001/02. The two largest functional components
of total health expenditure were ambulatory care (35-41%) and in-patient cura-
tive care (20-27%). Public spending generally financed in-patient curative care
and ambulatory services; private spending was concentrated on ambulatory serv-
ices and medical goods outside the patient care setting.
Conclusion. These data provide important information for the public,
policymakers, and researchers to assess the performance of the health care
system longitudinally, and to evaluate health expenditure-related policies.
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Introduction
An understanding of the financial dimensions of health care systems is increas-
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ingly recognised as an important contribution to health policy
development. In the developed world, especially those be-
longing to the Organisation for Economic Co-operation and
Development (OECD), systematic accounting of national
health expenditures has been carried out for several decades,
albeit in non-standardised ways until the publication of con-
sensus guidelines in 2000.1 This is a relatively new area of
intense focus in Hong Kong.
The creation of standardised definitions and accounting
methods across countries and the routine collection of data
have provided the means for informative and productive
inquiry into the financial and health implications of macro
patterns of health care financing. Health accounts are an
important tool that demonstrates how a territory’s health re-
sources are spent, on what services, and who pays for them.
National or domestic health accounts (NHA/DHA) de-
scribe systematically and accurately the totality of health
care expenditure flows in both government and non-
government sectors. National or domestic health accounts
achieve this by identifying the sources of all funds utilised
in the sector, ascertaining the uses of these funds, and dem-
onstrating how they are spent. Overall, NHA/DHA provide
essential data for health sector planning and management,
in the same way that national income accounts and vital
statistics provide essential data for macro-economic
planning, and population and social service planning
respectively.1,2
Properly constructed NHA/DHA that conform to inter-
national standards can achieve the following:
(1) Track secular changes in health resource inflow and
outflow and provide time-series estimates.
(2) Provide national, international, and cross-regional
comparisons and benchmarking so that best practices
can be learned and adopted.
(3) Serve as a baseline before any major reforms are made
to health financing infrastructure and allow evaluation
and monitoring of new macro financing policies and
instruments, such as those Hong Kong is currently facing.
(4) Support and promote good governance and steward-
ship of the health system as Hong Kong moves
forward in its health system reforms.
(5) Provide the necessary fiscal data infrastructure to study
and examine condition-specific (eg for major disease
groups) health accounting and resource allocation.
(6) Strengthen the research-policy link and reinforce the
importance of integrating research and development
in the policy formulation process.
In June 2002 the China National Health Accounts Task
Force of the China Health Economics Institute, Ministry of
Health in Beijing released their first set of NHA for the years
1990 to 1999. In Hong Kong, the first set of DHA was de-
veloped as part of the Harvard consultancy published in
1999. Since then, the University of Hong Kong School of
Public Health has been commissioned to undertake an
updating exercise with estimates up to fiscal year 2001/02.
Methods
Development process
In 2002, 5 years after the first set of DHA was constructed
in 1997, we sought to update the conceptual framework and
classification system based on the latest OECD guidelines—
A System of Health Accounts v1.0 released in 2000.1 In
reconfiguring the structure and compilation process of the
DHA to be in line with the latest international guidelines,
vis-à-vis OECD standards, subsequent national, and
cross-territorial comparisons and benchmarking became
possible.
The conceptual framework involves the definition of
what constitutes health expenditure, the institutional enti-
ties involved, the specification of the types of disaggrega-
tion involved, and the standard reporting formats. The
structure includes the classifications and nomenclature used
to identify and disaggregate expenditures, either by func-
tion or purpose, type or ultimate beneficiary, and the tem-
poral reference period.
The conceptual framework and classification structure
for Hong Kong’s DHA was developed through a Delphi-
like process of consultation with various stakeholders in
health and health care and members of the Hong Kong Do-
mestic Health Account Steering Committee. The following
criteria were applied:
(1) Policy relevance and easy comprehension;
(2) Reproducibility;
(3) Categories used in classifications should be mutually
exclusive;
(4) Timeliness of reporting given secondary data availability,
or with limited primary data collection; and
(5) Compatibility with international practice and norms to
the extent possible.
Definition of health expenditure
Health spending consists of health and health-related
expenditures. Expenditures are defined on the basis of their
primary or predominant purpose of improving health, re-
gardless of the primary function or activity of the entity pro-
viding or paying for the associated health services. Health
includes both the health of individuals and of groups of
individuals or populations. Health expenditure consists of
all expenditure or outlay for medical care, prevention,
promotion, rehabilitation, community health activities,
health administration and regulation, and capital formation
with the predominant objective of improving health. Health-
related expenditure includes expenditure on health-related
functions such as medical education and training, and re-
search and development.1,3
Domestic health expenditure for the Hong Kong DHA
is defined as all health expenditure for the benefit of indi-
viduals resident in Hong Kong. Expenditure for the benefit
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Accounting basis
All estimates are based on a fiscal year (1 April to 31 March)
cycle, in line with much of the data available. Ideally, ex-
penditure should be measured on an accrual basis. None-
theless public expenditure is reported on a cash basis, thus
domestic health expenditure was estimated based on cash
accounting principles.
Temporal scope
This report presents estimates of domestic health expendi-
ture in Hong Kong between fiscal years 1989/90 and 2001/
02, with retrospective updating and revision of the previous
1989/90 to 1996/97 estimates based on the current concep-
tual framework and classification system. This facilitates
time trend analysis. Both gross domestic product (GDP) and
DHA estimates are standardised for the fiscal year 1 April
through 31 March.
Sources of data
The estimates of Hong Kong’s DHA were compiled from
many sources of information. Most public expenditure data
were obtained from government financial accounts, whilst
private sector expenditure was based largely on estimates
from surveys that are likely to be less accurate. Total
domestic health expenditure (TDHE) is considered to be
accurate to within 0.25% of GDP.
This final set of estimates of domestic health ex-
penditure has been endorsed by the Hong Kong DHA Steer-
ing Committee.
Results
Total domestic health expenditure was estimated to be
$68 620 million in the fiscal year 2001/02, with annual per
capita spending at $10 204. In real terms, after removal of
the impact of inflation, TDHE grew at an average annual
rate of 7% from $30 284 million in 1989/90 to $70 424
million in 2001/02 at constant 2000 prices (Table 1). Real
GDP grew at a lower rate of 4%. Consequently, total
health spending as a share of GDP increased from 3.8% in
1989/90 to 5.5% in 2001/02 (Table 1). On a per capita basis,
TDHE grew at 6% per annum on average over the period
1989/90 through 2000/01 in real terms, while GDP grew at
a rate of only 3% during the same period (a mixed trend of
sustained robust economic growth from 1989/90 until the
Asian financial crisis in 1997/98).
Public expenditure at constant 2000 prices grew 208%
from $13 013 million in 1989/90 to $40 105 million in
2001/02, compared with a corresponding increase of 76%
(from $17 270 million to $30 818 million) for private expend-
iture. This represents a growing share of public spending
from 43% to 57% of TDHE during the period (Table 1).
Public spending also accounted for an increasing share of
GDP, from 1.6% in 1989/90 to 3.1% in 2001/02, whereas
private spending was maintained at a relatively stable level
of between 2.2% and 2.3%. Figure 1 shows the mix of pri-
of Hong Kong citizens living abroad is excluded, although
expenditure in other countries for the benefit of Hong Kong
residents is included, as well as expenditure for the benefit
of expatriates residing in Hong Kong.
Total domestic expenditure on health includes all direct
health expenditure, plus gross capital formation in health
care provider industries, ie institutions where health care is
the predominant activity.
Classification system
Hong Kong’s DHA has adopted the International Classifi-
cation for Health Accounts (ICHA) developed by the OECD.1
The ICHA was designed to be compatible with a number of
existing classification schemes and practices in international
economic statistics, eg national income accounts. It is a
comprehensive classification system with three important
dimensions—financing sources, health providers and
functions, and health-related functions. Domestic health
expenditure is measured and organised on the basis of
the entities making the expenditure, and those entities
passing or using the expenditure. In terms of the three key
dimensions:
(1) Financing sources are defined as entities that directly
incur the expenditure and hence control and finance
the amount of such expenditure;
(2) Health providers are defined as institutional entities that
produce and provide health care goods and services
that benefit individuals, groups of individuals or whole
populations; and
(3) All health expenditure is divided into two categories,
core health functions or health-related functions. Hong
Kong’s DHA makes a distinction between in-patient
and out-patient care and also recognises separately
rehabilitative care, long-term nursing care, ancillary
services, and medical goods dispensed to out-patients.
In the subcategory of over-the-counter medicines, a
further distinction is made between ‘western’ and
‘traditional (including Chinese medicine) and others’.
Continuity with previous domestic health accounts
estimates and compatibility with international norms
The first compilation of the DHA for the years 1989/90
through 1996/97 resulted in a provisional functional classi-
fication system for Hong Kong, with reference to a 1998
pre-publication draft of the OECD guidelines. The present
update made substantial revisions to that earlier framework
in accordance with 2000 guidelines and subsequent
revisions. We offered a harmonisation of the revised defini-
tions and those used in the first DHA exercise in 1998 by
mapping the previous set of classification codes to those
used in the present exercise. Additionally, we constructed a
system to link the detailed Hong Kong–specific classifica-
tion system with the more generic, standard OECD
reporting system so that international comparisons were
possible. A full version of the conceptual framework
and classification system can be found online at the website:
www.hwfb.gov.hk.
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Fig 1. Mix of private health expenditures, 1989/90 to 2001/02
vate health spending between 1989/90 and 2001/02. Private
spending, mostly financed directly through households,
accounted for 30% of total spending in 2001/02. Employer
and insurance contributions were the other major sources,
making up about 12% of total health expenditure. Insur-
ance has played an increasingly important role in financing
private spending, and can be explained by the decrease in
share of household expenditures over the period while
employer expenditures stayed at a relative constant level of
private spending.
Stratified by provider categories, the largest share of
expenditure in 1989/90 was incurred at providers of ambu-
latory services (42%) and the second largest at hospitals
(27%). However, as a result of a gradual decrease in spend-
ing at providers of ambulatory services and a correspond-
ing increase in the number of service spectrum and quality
at hospitals during the period, hospitals accounted for the
largest (45%) and providers of ambulatory services the
second largest (30%) share of total spending in 2001/02
(Fig 2). Public expenditures were mostly incurred at
hospitals and accounted for 70% in 2001/02, whilst private
expenditures were mostly incurred at providers of ambula-
tory services (56% in 2001/02) [Table 2]. Other industries,
Table 1.  Total domestic health expenditures, 1989/90 to 2001/02
1989/90 1990/91 1991/92 1992/93 1993/94
At current market prices
QTDHE* (HK$ million) 20 450 24 730 30 200 34 247 40 047
QAnnual increase in TDHE - 21% 22% 13% 17%
GDP† (HK$ million) 539 908 605 590 704 905 820 225 943 611
Annual increase in GDP - 12% 16% 16% 15%
At constant 2000 prices
QTDHE (HK$ million) 30 284 34 224 38 002 39 486 42 705
QAnnual increase in TDHE - 13% 11% 4% 8%
GDP (HK$ million) 799 539 838 098 887 000 945 714 1 006 224
Annual increase in GDP - 5% 6% 7% 6%
Public share 43% 46% 48% 47% 49%
TDHE as a proportion of GDP 3.8% 4.1% 4.3% 4.2% 4.2%
* TDHE total domestic health expenditures
† GDP gross domestic product
‡ CW change within 0.5%
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which represent providers of investment in capital forma-
tion and medical facilities, constituted between 7% and 26%
of total public expenditure. For private expenditure, the other
significant element was retail sales and other providers of
medical goods that made up between 16% and 24% of total
private spending.
In terms of health and health-related expenditure by
function, services of curative care maintained the largest
share of total health spending during 1989/90 to 2001/02,
of which in-patient curative care and ambulatory services
accounted for about 60% of the total. Medical goods
outside the patient care setting and investment in medical
facilities constituted about one fifth of total spending and
prevention and public health services remained at 3% share.
Other health-related functions that do not fall under TDHE
accounted for 5% to 9% of total health and health-related
expenditures. Of these, education and training of health per-
sonnel remained at 2% to 3% while research and develop-
ment in health, and environmental health grew 1 percentage
point and 3 percentage points during the period, respectively.
Figure 3 compares the various functions as a share of total
spending for the year 1989/90 with 2001/02. In-patient
curative care increased 7 percentage points as a share of
total spending, while ambulatory services and investment
in medical facilities decreased 5 and 8 percentage points,
respectively. Table 3 shows public and private expenditures
by function during the period. Public spending mostly
financed in-patient curative care and ambulatory services,
whilst most private spending contributed towards ambula-
tory services and medical goods outside the patient care
setting. Table 3 also shows that day-patient hospital services,
home care, rehabilitative and extended care, long-term care,
prevention and public health services, and investment in
medical facilities were predominately financed by public
sources. Public and private spending both accounted for an
increasing share of in-patient curative care during 1989/90
to 2001/02, from 33% to 38% for public and from 11% to
13% for private. Ambulatory services as a share of govern-
ment spending increased from 15% to 24% while the share
Fiscal year
1994/95 1995/96 1996/97 1997/98 1998/99 1999/00 2000/01 2001/02
45 382 52 187 58 521 63 534 67 184 66 061 67 128 68 620
13% 15% 12% 9% 6% -2% 2% 2%
1 046 936 1 116 430 1 244 508 1 346 815 1 260 829 1 264 066 1 287 306 1 258 246
11% 7% 11% 8% -6% CW‡ 2% -2%
45 925 51 077 53 962 55 799 58 880 63 019 67 538 70 424
8% 11% 6% 3% 7% 5% 7% 4%
1 059 461 1 092 676 1 147 569 1 182 853 1 123 753 1 205 855 1 295 174 1 291 330
5% 3% 5% 3% -5% 7% 7% CW
49% 50% 52% 52% 55% 55% 56% 57%
4.3% 4.7% 4.7% 4.7% 5.3% 5.2% 5.2% 5.5%
Hospitals
Providers of ambulatory health care
Provision and administration of public health programmes
Other industries (rest of the economy)
Nursing and residential care facilities
Retail sale and other providers of medical goods
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Fig 2. Total health expenditure by provider, 1989/90 to 2001/02
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Fig 3. Total health expenditures by function, 1989/90 and 2001/02
of private spending decreased from 58% to 51%.
Discussion
These findings represent the most up-to-date health account-
ing information currently available in Hong Kong. They
Table 2.  Public versus private health expenditure by provider, 1989/90 to 2001/02
Provider
1989/90 1990/91 1991/92 1992/93
Public
QiHospitals 52% 53% 61% 65%
QiNursing and residential care facilities 2% 2% 2% 2%
QiProviders of ambulatory health care 13% 13% 11% 11%
QiRetail sale and other providers of medical goods 0% 0% 0% 0%
QiProvision and administration of public health programmes 5% 5% 5% 4%
QiGeneral health administration and insurance 2% 2% 1% 3%
QiOther industries (rest of the economy) 26% 26% 20% 14%
QiRest of the world 0% 0% 0% 0%
Public expenditures (HK$ million) 8788 11 256 14 569 16 250
Private
QiHospitals 8% 9% 9% 10%
QiNursing and residential care facilities 1% 1% 1% 1%
QiProviders of ambulatory health care 64% 64% 66% 66%
QiRetail sale and other providers of medical goods 20% 20% 19% 18%
QiProvision and administration of public health programmes 0% 0% 0% 0%
QiGeneral health administration and insurance 3% 3% 3% 3%
QiOther industries (rest of the economy) 3% 3% 2% 2%
QiRest of the world 0% 0% 0% 0%
Private expenditures (HK$ million) 11 662 13 473 15 632 17 997
provide a resource for assessing and understanding trends
and levels of health spending locally, across jurisdictions
and over time. Such data provide important information for
the public, policymakers, and researchers to assess the
performance of the domestic health system longitudinally,
and to evaluate health expenditure–related policies. These
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findings are a timely addition to the evidence base on
which health system reform options should be formulated
and evaluated. More specifically, the data provided here-
with can be used to, among other analyses, (1) project
future levels and trends of TDHE employing econometric
and/or actuarial approaches so as to inform the medium- to
long-term financial sustainability of the status quo and
potential reform options; and (2) assess the equity perform-
ance of the current financial arrangements in terms of the
progressivity of different forms of health payments, benefit-
incidence of public subsidies, catastrophic and poverty
impact of health spending, and horizontal equity of health
care utilisation.
In the estimation process, we encountered several
conceptual, definition, and methodological challenges that
bear mention, in order to share best practice with other ju-
risdictions that may be facing similar difficulties and thus
jointly develop solutions in future iterations of the OECD
standards. First, there might have been an artefactual, albeit
very small, inflation of private spending due to problems
defining operating deficits, for example in the case of the
Hospital Authority in recent years. Such deficits were ac-
counted for by two extra source categories called “HFS.2.6
Non-patient care-related revenue” (expenditure financed by
non-patient care-related revenue such as rental, interest or
investment income) and “HFS.2.7 Provider own funds”
(providers’ surplus from previous years or reserve) in the
Hong Kong classification scheme, both of which are con-
sidered “private” sources according to the OECD guide-
lines. The Hospital Authority is nonetheless clearly a public
provider and as such all funds, whether they are inter-
temporally transferred or otherwise could also be deemed
as “public” in nature. Second, in the OECD methodology,
depreciation is usually booked as an expenditure item in
providers’ income and expenditure statements, while capital
formation is booked as a change of fixed assets in providers’
balance sheet. This creates a dilemma of double-counting
the same item (eg construction costs of a new hospital wing)
over time, and remains an unresolved issue at the most re-
cent meeting of national health accounts experts and revi-
sion of OECD SHA 1.0 in October 2004. Third, the proper
accounting of expenditure in the control of infectious dis-
eases has yet to achieve consensus in the health accounts
community. For instance, expenditure on the actual culling
of poultry to control avian influenza was counted as health
expenditure, but compensation to poultry operators was not
included in the present estimation exercise, following guid-
ance sought specifically from the OECD Secretariat. One
could reasonably argue that both should be part of TDHE if
the overriding objective of health accounts is to include all
spending that has a “predominant purpose of improving
health”: the latter activity is a preventive intervention and
thus should be covered. Fourth, notwithstanding a recent
OECD document on refined definitions of long-term care,
the definition remains vague and difficult to interpret.
Additionally, the data required probably exceed routine data
collection in most territories, including Hong Kong. This
issue deserves urgent attention given the rapidly ageing
population and the growing importance of elderly care.
Finally, there are still limited local data on Chinese medi-
cine practitioner episodes, medical laboratories and diag-
nostic imagining facilities, employer-provided group
medical benefits, and medical goods outside the patient care
setting. More routine data gathering exercises, as opposed
to ad hoc surveys, to better inform the next round of estima-
tions should be instituted.
Since the formal launch of the OECD System of Health
Accounts in 2000, there have been significant attempts to
further refine the standardisation of NHA/DHA approaches,
with the ultimate objective of developing global standards
that are also locally responsive and policy relevant. In
the present exercise, we have maintained this delicate
Fiscal year
1993/94 1994/95 1995/96 1996/97 1997/98 1998/99 1999/00 2000/01 2001/02
64% 66% 66% 65% 67% 66% 69% 70% 70%
2% 2% 3% 3% 4% 4% 5% 5% 5%
11% 11% 11% 10% 11% 11% 11% 11% 11%
0% 0% 0% 0% 1% 1% 1% 1% 1%
4% 4% 4% 4% 4% 4% 4% 4% 4%
2% 2% 1% 1% 1% 1% 1% 1% 1%
16% 14% 14% 15% 13% 13% 9% 8% 7%
0% 0% 0% 0% 0% 0% 0% 0% 0%
19 541 22 314 26 169 30 291 33 128 37 009 36 601 37 449 39 078
9% 10% 10% 9% 9% 9% 9% 10% 12%
1% 1% 1% 1% 1% 1% 1% 1% 1%
66% 67% 65% 66% 64% 62% 60% 58% 56%
17% 16% 16% 17% 18% 20% 22% 24% 24%
0% 0% 0% 0% 0% 0% 0% 0% 0%
3% 4% 5% 6% 5% 5% 6% 6% 6%
3% 3% 3% 2% 2% 2% 1% 1% 1%
0% 0% 0% 0% 0% 0% 0% 0% 0%
20 506 23 068 26 018 28 230 30 406 30 175 29 460 29 679 29 542
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balancing process between local compatibility with statis-
tics (eg domestic income accounts) produced by the
Government Treasury and Census and Statistics Department,
usefulness to policy deliberations by the Health, Welfare
and Food Bureau and other stakeholders, comprehensibil-
ity by the general public in addition to comparability across
countries for benchmarking purposes. We believe we have
achieved a sufficient degree of detail that permits further
disaggregation, reconstitution, and customisation for local
needs and priorities (in the form of a multi-dimensional
relational database that can be queried in different ways
and produce results in a multitude of formats), while simul-
taneously allowing for the production of summary data to
meet the needs of an emerging international standard.
Future work should focus on developing a web-based
interactive information system for public and executive
inquiry regarding domestic health expenditure, at various
pre-defined levels of disaggregated details to protect
privacy and confidentiality of the parties involved. Such
a dissemination tool would promote further discussion
and dialogue, and in turn facilitate policy design and
implementation.
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Table 3.  Public versus private health expenditures by function, 1989/90 to 2001/02
Function
1989/90 1990/91 1991/92 1992/93
Public
QiServices of curative care 53% 53% 60% 64%
QQiIn-patient curative care 33% 33% 36% 38%
QQiDay-patient hospital services 5% 5% 5% 5%
QQiAmbulatory services 15% 15% 18% 20%
QQiHome care 0% 0% 0% 0%
QiRehabilitative and extended care 5% 5% 5% 6%
QiLong-term care 5% 5% 5% 5%
QiAncillary services to health care 4% 4% 3% 4%
QiMedical goods outside the patient care setting 0% 0% 0% 0%
QiPrevention and public health services 6% 6% 5% 5%
QiHealth programme administration and health insurance 2% 2% 1% 3%
QiInvestment in medical facilities 26% 26% 20% 14%
Public expenditures (HK$ million) 8788 11 256 14 569 16 250
Private
QiServices of curative care 69% 70% 71% 72%
QQiIn-patient curative care 11% 11% 11% 12%
QQiDay-patient hospital services 0% 0% 0% 0%
QQiAmbulatory services 58% 59% 60% 60%
QQiHome care 0% 0% 0% 0%
QiRehabilitative and extended care 0% 0% 0% 0%
QiLong-term care 1% 1% 1% 1%
QiAncillary services to health care 2% 2% 2% 2%
QiMedical goods outside the patient care setting 21% 21% 20% 19%
QiPrevention and public health services 0% 0% 0% 0%
QiHealth programme administration and health insurance 3% 3% 3% 3%
QiInvestment in medical facilities 3% 3% 2% 2%
Private expenditures (HK$ million) 11 662 13 473 15 632 17 997
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Hong Kong’s domestic health expenditure
Fiscal year
1993/94 1994/95 1995/96 1996/97 1997/98 1998/99 1999/00 2000/01 2001/02
62% 64% 64% 63% 65% 64% 67% 68% 68%
37% 38% 38% 38% 39% 38% 38% 38% 38%
5% 5% 5% 5% 5% 5% 5% 5% 6%
20% 21% 21% 20% 21% 21% 23% 23% 24%
0% 0% 0% 0% 1% 1% 1% 1% 1%
6% 6% 6% 6% 6% 6% 7% 6% 7%
5% 5% 6% 6% 7% 7% 8% 8% 8%
4% 4% 3% 3% 3% 3% 3% 3% 3%
0% 0% 0% 0% 1% 1% 1% 1% 1%
5% 5% 5% 5% 5% 5% 5% 5% 5%
2% 2% 1% 1% 1% 1% 1% 1% 1%
16% 14% 14% 15% 13% 13% 9% 8% 7%
19 541 22 314 26 169 30 291 33 128 37 009 36 601 37 449 39 078
71% 72% 71% 70% 69% 68% 67% 65% 65%
12% 12% 12% 11% 11% 11% 12% 12% 13%
0% 0% 0% 0% 0% 0% 0% 0% 0%
59% 60% 59% 59% 58% 56% 55% 53% 51%
0% 0% 0% 0% 0% 0% 0% 0% 0%
0% 0% 0% 0% 0% 0% 0% 0% 0%
1% 1% 1% 1% 1% 1% 1% 1% 1%
2% 2% 2% 2% 2% 2% 2% 2% 2%
19% 18% 18% 19% 20% 21% 23% 24% 24%
0% 0% 0% 0% 0% 0% 0% 0% 0%
3% 4% 5% 6% 5% 5% 6% 6% 6%
3% 3% 3% 2% 2% 2% 1% 1% 1%
20 506 23 068 26 018 28 230 30 406 30 175 29 460 29 679 29 542
